For ophthalmic use only. Instill one drop into the conjunctival sac of the affected eye(s). Avoid touching the dropper tip to the eye or any other surface.

It reduces aqueous humor production, thereby lowering intraocular pressure. As a beta1-selective blocker, it has less potential for pulmonary and cardiovascular side effects than nonselective beta-blockers.

• •Sinus bradycardia
• •Second- or third-degree atrioventricular block
• •Overt cardiac failure
• •Cardiogenic shock
• •Hypersensitivity to betaxolol or any component of the formulation

Store at room temperature (15-30°C), protect from light. Do not freeze.

Systemic overdose is unlikely with ophthalmic use. If swallowed, symptoms may include bradycardia, hypotension, and bronchospasm. Symptomatic and supportive treatment.

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution should be exercised when administered to a nursing woman.